“Purity by NMR: making it robust and automated”
Our colleague Dr. Michael Bernstein will discuss issues and solutions to the automation of qNMR Purity analysis.
Compound purity using quantitative NMR (qNMR) is an established, tested, and trusted analytical method. There are good reasons to automate qNMR Purity, considering the robustness of the method, GxP issues, and throughput.
We will primarily consider the existing methods for qNMR Purity automation. Existing methods focus on post-acquisition considerations, and we will discuss the considerations required for a fully automated recording implementation.
- qNMR Purity automation
- Designing for robustness
- Reduce need for highly-trained analysts
Who should attend?
- Analytical chemists working in pharmaceutical or fine chemicals science
- qNMR Purity in GxP environments
- Validated procedure implementation
- Focus on higher throughput
ABOUT THE SPEAKER
Dr. Michael Bernstein
Dr. Michael (“Mike”) Bernstein is responsible for R&D aspects of Mestrelab Research. Particular emphasis is on suitability for use by chemists, and developing capability around the use of NMR for quantitation. With over 30 years of pharmaceutical experience with NMR first at Merck Frosst (MSDRL) in Montreal, and then at Astra Zeneca in the UK. He joined Mestrelab in 2011.
Extended bio about Dr. Michael Bernstein.